Código QR (código de barras bidimensional)

Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer

<i>Background</i>: Hormone receptor-positive and HER2-negative breast cancer (HR + BC) is the most prevalent breast cancer. Endocrine therapy is the mainstay of treatment, however, due to the heterogeneous nature of the disease, resistance to endocrine therapy is not uncommon. Over the past decades,...

ver descrição completa

Na minha lista:
Principais autores: Samitha Andrahennadi, Amer Sami, Mita Manna, Mehrnoosh Pauls, Shahid Ahmed
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2021-05-01
coleção:Current Oncology
Assuntos:
breast cancer
hormone receptor-positive breast cancer
estrogen receptor-positive-breast cancer
systemic therapy
targeted therapy
antiestrogen therapy
Acesso em linha:https://www.mdpi.com/1718-7729/28/3/168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados